epigallocatechin gallate has been researched along with hypoxanthine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabezas-Herrera, J; Campo, LS; Navarro-Perán, E; Rodríguez-López, JN | 1 |
| Koetje, LR; Mitchell, AK; Schotanus, MP; Stoddard, AR; Ubels, JL | 1 |
2 other study(ies) available for epigallocatechin gallate and hypoxanthine
| Article | Year |
|---|---|
Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate.
Topics: Adenosine; Apoptosis; Caco-2 Cells; Camellia sinensis; Caspase 3; Catechin; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; DNA Replication; Fluorouracil; Folic Acid Antagonists; Gene Expression; Humans; Hypoxanthine; Leucovorin; Models, Biological; NF-kappa B; Protein Binding; Receptor, Adenosine A3; Tetrahydrofolate Dehydrogenase; Thymine; Transcription, Genetic | 2007 |
Bioavailability of antioxidants applied to stratified human corneal epithelial cells.
Topics: Amidines; Antioxidants; Biological Availability; Catechin; Cells, Cultured; Epithelium, Corneal; Fluoresceins; Humans; Hypoxanthine; Limbus Corneae; Oxidants; Quercetin; Reactive Oxygen Species; Tissue Distribution; Xanthine Oxidase | 2013 |